OCGN FY 2018 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$49,623

Operating Income

-$30M

Net Income

-$9M

EPS (Diluted)

$-13.98

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$17M

Total Liabilities

$18M

Stockholders' Equity

-$458,000

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$49,623	-$2M	+96.8%
Operating Income	-$30M	-$25M	-20.7%
Net Income	-$9M	-$26M	+67.3%